COM:XBIOTECH
XBiotech
- Stock
Last Close
6.62
22/11 21:00
Market Cap
208.20M
Beta: -
Volume Today
37.41K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
asset turnover | 0.12 - | 0.07 46.26% | 0.02 75.62% | |||||||||
cash conversion cycle | -7.11 - | -513.58 7,121.11% | -1.19K 131.62% | |||||||||
cash per share | 0.23 - | 1.81 691.40% | 2.96 63.54% | 1.06 64.17% | 0.91 14.01% | 0.44 51.48% | 18.35 4,051.92% | 7.70 58.03% | 7.89 2.43% | 7.14 9.42% | 6.57 8.02% | |
company equity multiplier | 1.08 - | 1.05 2.71% | 1.06 0.75% | 1.14 6.97% | 1.05 7.80% | 1.07 2.34% | 1.08 0.92% | 1.01 6.14% | 1.02 0.68% | 1.02 0.22% | 1.04 1.43% | |
days of inventory outstanding | -69.45 - | -561.49 708.42% | ||||||||||
days of payables outstanding | 26.32 - | 129.76 393.05% | 1.35K 940.49% | 526.57 61.00% | ||||||||
days of sales outstanding | 88.66 - | 177.66 100.38% | 160.56 9.62% | |||||||||
dividend yield | 0.22 - | |||||||||||
ebit per revenue | -0.42 - | -1.36 228.27% | -8.60 530.76% | |||||||||
ebt per ebit | 1.00 - | 1.00 0.27% | 1.00 0.18% | 1.00 0.07% | 0.97 2.67% | 1.01 3.45% | -23.00 2,384.63% | 0.70 103.05% | 1.01 44.62% | 0.97 4.05% | 0.65 33.44% | |
effective tax rate | -0.00 - | 0.00 1,333.79% | 0.00 93.56% | 0.00 76.32% | 0.03 72,237.48% | 0.01 75.16% | 0.07 917.99% | 0.13 80.54% | 0.32 152.36% | 0.02 93.52% | -0.01 148.99% | |
enterprise value multiple | -79.90 - | -32.13 59.79% | -6.62 79.39% | -5.64 14.75% | -3.19 43.50% | -9.22 189.11% | -0.44 95.22% | -12.54 2,748.39% | -4.48 64.25% | 1.74 138.71% | 2.19 26.09% | |
fixed asset turnover | 1.61 - | 0.65 59.63% | 0.15 76.50% | |||||||||
free cash flow per share | -0.28 - | -0.41 46.06% | -1.42 243.57% | -1.85 30.36% | -1.01 45.65% | -0.47 53.71% | -0.47 1.95% | -2.23 371.07% | 2.19 198.19% | -0.51 123.07% | -0.63 23.87% | |
gross profit margin | 0.21 - | 0.68 218.30% | 0.84 22.54% | |||||||||
interest coverage | 38.24 - | |||||||||||
inventory turnover | -5.26 - | -0.65 87.63% | ||||||||||
long term debt to capitalization | ||||||||||||
net income per ebt | 1 - | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 0.93 6.93% | 0.87 6.00% | 0.68 21.81% | 0.98 43.20% | 1.01 3.12% | |
net profit margin | -0.26 - | -0.95 271.21% | -8.20 766.62% | |||||||||
operating cash flow per share | -0.28 - | -0.37 31.34% | -1.08 193.14% | -1.42 31.32% | -0.96 32.06% | -0.46 52.13% | -0.47 1.57% | -2.11 350.55% | 2.31 209.36% | -0.49 121.07% | -0.62 26.32% | |
operating cycle | 19.21 - | -383.83 2,098.56% | 160.56 141.83% | |||||||||
operating profit margin | -0.42 - | -1.36 228.27% | -8.60 530.76% | |||||||||
payables turnover | 13.87 - | 2.81 79.72% | 0.27 90.39% | 0.69 156.40% | ||||||||
pretax profit margin | -0.29 - | -1.38 374.73% | -8.38 505.19% | |||||||||
price fair value | 72.10 - | 12.49 82.67% | 3.25 73.99% | 5.55 70.88% | 2.28 58.86% | 4.39 92.36% | 0.96 78.10% | 1.38 43.83% | 1.24 10.29% | 0.44 64.20% | 0.56 25.18% | |
receivables turnover | 4.12 - | 2.05 50.10% | 2.27 10.65% | |||||||||
return on assets | -0.90 - | -0.35 61.03% | -0.34 1.90% | -0.79 129.58% | -0.53 33.10% | -0.48 9.45% | 0.82 271.72% | -0.03 103.88% | -0.06 99.50% | -0.13 111.25% | -0.11 19.16% | |
return on capital employed | -0.97 - | -0.37 61.98% | -0.36 1.35% | -0.89 145.36% | -0.57 36.62% | -0.51 10.40% | -0.04 91.86% | -0.05 26.59% | -0.09 76.65% | -0.14 54.38% | -0.17 19.03% | |
return on equity | -0.97 - | -0.37 62.08% | -0.36 1.16% | -0.89 145.59% | -0.55 38.32% | -0.51 7.33% | 0.88 273.30% | -0.03 103.64% | -0.06 100.85% | -0.14 111.71% | -0.11 18.01% | |
total debt to capitalization |
All numbers in (except ratios and percentages)